Novel Targeted Pro-Apoptotic Agents for the Treatment of Prostate Cancer
To access this article, please choose from the options below
For another article on a related topic see page 2176.
Supported by Department of Defense Grant W81XWH-05-1-0080, National Institutes of Health Grant DK64062 and Howard Hughes Medical Institute/SPORE Grant 53000234-0006 to the Biomedical Research Support Program at Harvard Medical School (AFO).
PII: S0022-5347(07)01671-0
doi:10.1016/j.juro.2007.06.039
© 2007 American Urological Association. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Effect of α1-Adrenoceptor Antagonist Exposure on Prostate Cancer Incidence: An Observational Cohort Study , 17 September 2007

